Retinal vasoproliferative tumor regression after intravitreal aflibercept by Ting-Wen Chu, Shawn H Tsai, Lee-Jen Chen

Subjects: Get full text

Effects of small molecule inhibitors targeting PI3K, EGFR, IGF-1R, MTOR, SMAD3 and MEK in tube formation and 3-D spheroid assay by Ng, Chin Tat

Subjects: “…Angiogenesis Inhibitors…”
Get full text

Comparative characteristics of the outcomes of the use of multidirectional intravitreal pharmacotherapy in the treatment of diabetic macular edema by M. M. Bikbov, K. I. Kudoyarova, R. M. Zainullin, T. R. Gilmanshin

Subjects: Get full text

Ibrutinib Inhibits Angiogenesis and Tumorigenesis in a BTK-Independent Manner by Jia Liu, Zhuojun Liu, Jing Zhang, Xiaofang Chen, Junge Chen, Linlin Sui, Jian Yu

Subjects: Get full text

A MgAl-LDH-CuS nanosheet-based thermo-responsive composite hydrogel with nir-responsive angiogenesis inhibitor releasing capability for multimode starvation therapy by Xueyan Liu, Tingting Hu, Yijiang Jia, Shuqing Yang, Yu Yang, Zhuolin Cui, Tao Wang, Ruizheng Liang, Chaoliang Tan, Yuji Wang

Subjects: Get full text

Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022 by Yanfeng Wang, Chanjuan Cui, Lei Deng, Lin Wang, Xiayang Ren

Subjects: Get full text

Zoledronate/Anti-VEGF Neutralizing Antibody Combination Administration Increases Osteal Macrophages in a Murine Model of MRONJ Stage 0-like Lesions by Haruka Kaneko, Shinichiro Kuroshima, Ryohei Kozutsumi, Farah A. Al-Omari, Hiroki Hayano, Kazunori Nakajima, Takashi Sawase

Subjects: Get full text

Nintedanib antiangiogenic inhibitor effectiveness in delaying adenocarcinoma progression in Transgenic Adenocarcinoma of the Mouse Prostate (TRAMP) by Raquel Frenedoso da Silva, Ellen Nogueira-Pangrazi, Larissa Akemi Kido, Fabio Montico, Sarah Arana, Dileep Kumar, Komal Raina, Rajesh Agarwal, Valéria Helena Alves Cagnon

Subjects: Get full text

A case of retinal tear associated with use of sorafenib by Kelly M. Gaertner, Stephen H. Caldwell, Osama eRahma

Subjects: Get full text

Green synthesis of Ag-NPs as a metal nanoparticle and ZnO-NPs as a metal oxide nanoparticle: Evaluation of the in vitrocytotoxicity, anti-oxidant, anti-angiogenic activities by Hoda Shabestarian, Masoud Homayouni Tabrizi, Monireh Movahedi, Ali Neamati, Fariba Sharifnia

Subjects: “…angiogenesis inhibitors…”
Get full text

Vasculogenesis and angiogenesis in diabetes mellitus: novel pathogenetic concepts for treatment of vascular complications by Vladimir Iosifovich Konenkov, Vadim Valer'evich Klimontov

Subjects: Get full text

Novel Multitarget Therapies for Lung Cancer and Respiratory Disease by Masako Yumura, Tatsuya Nagano, Yoshihiro Nishimura

Subjects: Get full text

Medication-Related Osteonecrosis of the Jaw—A Continuing Issue by Krzysztof Wróbel, Maciej Sikora, Maciej Chęciński, Maria Jas, Dariusz Chlubek

Subjects: Get full text

Editorial: Combination strategies in the treatment of Melanoma by Paolo Antonio eAscierto

Subjects: “…Angiogenesis Inhibitors…”
Get full text

First‐line immunotherapy or angiogenesis inhibitor combined with chemotherapy for advanced non‐small cell lung cancer with EGFR exon 20 insertions: Real‐world evidence from China by Guangjian Yang, Yaning Yang, Runze Liu, Weihua Li, Haiyan Xu, Xuezhi Hao, Junling Li, Shuyang Zhang, Fei Xu, Siyu Lei, Yan Wang

Subjects: “…angiogenesis inhibitor…”
Get full text

Efficacy and safety of EGFR-TKIs in combination with angiogenesis inhibitors as first-line therapy for advanced EGFR-mutant non-small-cell lung cancer: a systematic review and meta-analysis by Di Hu, Yan-Yan Zhou, Hong-Bo Ma, Miao-Miao Tao, Qun-Zhen Huang, Zhen-Zhou Yang, Qi Zhou

Subjects: Get full text

Randomised phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus trifluridine/tipiracil for previously treated patients with advanced gastric or esophago... by Naoki Takahashi, Hiroki Hara, Kengo Nagashima, Kenro Hirata, Toshiki Masuishi, Toshihiko Matsumoto, Hisato Kawakami, Kentaro Yamazaki, Shuichi Hironaka, Narikazu Boku, Kei Muro

Subjects: Get full text

Efficacy and safety of low‐dose apatinib in ovarian cancer patients with platinum‐resistance or platinum‐refractoriness: A single‐center retrospective study by Wei Chen, Ziting Li, Zhong Zheng, Xiaohua Wu

Subjects: “…angiogenesis inhibitor…”
Get full text

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer by Zhongmian Pan, Zhongbin Luo, Hongying He, Yujie Chen, Bingbing Zhao, Zhijun Yang, Li Li

Subjects: Get full text

On-Target Side Effects of Targeted Therapeutics of Cancer by József Tímár, Andrea Uhlyarik

Subjects: Get full text